Smoking slowly changes lung cells to increase the odds for cancer
Cigarette smoke causes epigenetic changes in lung cells that prime them to develop cancer, and researchers can now observe how these changes unfold over time....
Cigarette smoke causes epigenetic changes in lung cells that prime them to develop cancer, and researchers can now observe how these changes unfold over time....
Credit: Jennifer Fairman Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form...
Credit: Children's Hospital of Philadelphia Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy--harnessing ..
Credit: {FEATUREDCREDIT}{FEATUREDCREDITMORE} WASHINGTON, D.C., September 11, 2017 -- Researchers are starting to discover the curing powers of plasma -- bringing the ion-based form of matter...
Liver cancer occurs predominantly in patients whose liver has been damaged as a result of chronic disease. Until now it has remained in the dark...
PHILADELPHIA -- (Sept. 11, 2017) -- T lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients...
Credit: Photo courtesy of: UCLA Jonsson Comprehensive Cancer Center Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at...
Credit: Baylor College of Medicine The discovery of a mechanism by which normal brain cells regulate the expression of the NFIA gene, which is important...
Milan, 11 September 2017 - The names of the 2017 Balzan Prizewinners were disclosed today in a public announcement: Aleida and Jan Assmann (Germany), Universities...
CHAPEL HILL -- A study by researchers at the University of North Carolina Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost...
Credit: Karl Harrison A team of scientists led by the University of Southampton has demonstrated a groundbreaking new method of gene synthesis - a vital...
LUGANO-MADRID, 11 September, 2017 - Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to...
LUGANO-MADRID, 11 September, 2017 - Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage III/IV melanoma who are at...
LUGANO-MADRID, 11 September, 2017 - Immunotherapy with the checkpoint inhibitor pembrolizumab may be a better option than standard treatments for patients whose head and neck...
LUGANO-MADRID, 11 September, 2017 - The debate on whether to shorten adjuvant chemotherapy for colon cancer from six to three months takes centre stage today...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.